Total Payments
$13,012
2024 Payments
$1,594
Companies
55
Transactions
760
Medicare Patients
1,717
Medicare Billing
$156,022
Payment Breakdown by Category
Food & Beverage$12,961 (99.6%)
Education$51.34 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,961 | 750 | 99.6% |
| Education | $51.34 | 10 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,073 | 91 | $0 (2024) |
| ABBVIE INC. | $1,575 | 121 | $0 (2024) |
| Amgen Inc. | $1,291 | 65 | $0 (2024) |
| Novo Nordisk Inc | $1,124 | 60 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $747.36 | 44 | $0 (2024) |
| Amarin Pharma Inc. | $615.25 | 39 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $482.40 | 30 | $0 (2022) |
| Astellas Pharma US Inc | $438.40 | 27 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $373.81 | 21 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $372.61 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,594 | 74 | AstraZeneca Pharmaceuticals LP ($556.08) |
| 2023 | $1,531 | 89 | ABBVIE INC. ($509.54) |
| 2022 | $2,534 | 139 | ABBVIE INC. ($494.64) |
| 2021 | $2,393 | 157 | AbbVie Inc. ($313.83) |
| 2020 | $1,352 | 103 | Amarin Pharma Inc. ($178.34) |
| 2019 | $1,400 | 75 | AstraZeneca Pharmaceuticals LP ($325.33) |
| 2018 | $1,289 | 68 | Amgen Inc. ($461.34) |
| 2017 | $919.29 | 55 | Amgen Inc. ($199.10) |
All Payment Transactions
760 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Endocrinology | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.93 | General |
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: PAIN | ||||||
| 10/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $116.38 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: UROLOGY | ||||||
| 10/15/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: PAIN | ||||||
| 10/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Inflammation | ||||||
| 10/03/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/24/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $116.23 | General |
| Category: Respiratory | ||||||
| 09/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Oncology | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.26 | General |
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Respiratory | ||||||
| 09/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Cardio-renal | ||||||
| 09/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,353 | 3,423 | $282,194 | $136,692 |
| 2022 | 5 | 364 | 417 | $35,351 | $19,330 |
Total Patients
1,717
Total Services
3,840
Medicare Billing
$156,022
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 317 | 793 | $138,775 | $69,130 | 49.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 299 | 770 | $92,400 | $44,239 | 47.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 327 | 1,129 | $16,935 | $9,356 | 55.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 85 | 86 | $6,450 | $6,179 | 95.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 85 | 86 | $5,934 | $2,488 | 41.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 26 | 38 | $2,926 | $1,411 | 48.2% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 33 | 37 | $6,179 | $1,332 | 21.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 11 | 17 | $2,312 | $756.07 | 32.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 52 | $2,132 | $536.01 | 25.1% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 21 | 36 | $756.00 | $322.49 | 42.7% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 44 | 76 | $2,356 | $236.32 | 10.0% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 11 | 14 | $700.00 | $226.80 | 32.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 22 | 23 | $2,139 | $224.91 | 10.5% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 14 | 15 | $555.00 | $198.94 | 35.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 14 | 15 | $465.00 | $33.00 | 7.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 20 | 236 | $1,180 | $23.00 | 1.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 139 | 176 | $21,116 | $11,722 | 55.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 45 | $7,875 | $4,332 | 55.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 30 | 30 | $2,250 | $2,056 | 91.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 30 | 30 | $2,070 | $824.70 | 39.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 121 | 136 | $2,040 | $396.07 | 19.4% |
About Dr. David Moon, M.D
Dr. David Moon, M.D is a Family Medicine healthcare provider based in Lake City, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417053133.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Moon, M.D has received a total of $13,012 in payments from pharmaceutical and medical device companies, with $1,594 received in 2024. These payments were reported across 760 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($12,961).
As a Medicare-enrolled provider, Moon has provided services to 1,717 Medicare beneficiaries, totaling 3,840 services with total Medicare billing of $156,022. Data is available for 2 years (2022–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Lake City, SC
- Active Since 09/16/2006
- Last Updated 05/15/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1417053133
Products in Payments
- FARXIGA (Drug) $1,479
- VRAYLAR (Drug) $907.38
- Ozempic (Drug) $630.29
- Vascepa (Drug) $615.25
- XARELTO (Drug) $451.25
- JARDIANCE (Drug) $445.96
- MYRBETRIQ (Drug) $413.06
- Aimovig (Biological) $381.41
- Kerendia (Drug) $359.99
- QULIPTA (Drug) $325.38
- UBRELVY (Drug) $294.88
- XIFAXAN (Drug) $272.42
- Rybelsus (Drug) $256.35
- ENTRESTO (Drug) $248.24
- BREZTRI (Drug) $240.55
- Prolia (Biological) $239.39
- NALOCET (Drug) $215.49
- Otezla (Drug) $201.18
- TRINTELLIX (Drug) $197.89
- Repatha (Biological) $197.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lake City
Miguel Tepedino, Md, MD
Family Medicine — Payments: $71,706
Family Medicine $71,706
Dr. Richard Wright, M.d, M.D
Family Medicine — Payments: $17,641
Family Medicine $17,641
Ernest De Leon, Md, MD
Family Medicine — Payments: $17,392
Family Medicine $17,392
Dr. Daniel Decamps, M.d, M.D
Family Medicine — Payments: $11,529
Family Medicine $11,529
Jean-Felert Cadet, M.d Mph, M.D MPH
Family Medicine — Payments: $5,750
Family Medicine $5,750
Dr. David Rodriguez, M.d, M.D
Family Medicine — Payments: $5,322
Family Medicine $5,322